ADP-dependent glucokinase (ADPGK) is overexpressed in prostate adenocarcinoma and has been shown to promote PCa cell proliferation and migration in vitro and in vivo, while predicting poor prognosis of patients 124. This evidence concerns the gene ADPGK and prostate adenocarcinoma.